Genmab — Januar 2020

[Helge_LarsenPI-redaktør]

Ola Landgren, M.D.
@DrOlaLandgren
·
6 t
Svarer
@BrizzleDoc
og
@VJHemOnc
We showed at ASH 2019: (1) No additional grade >3 toxicities with weekly KRd-daratumumab (vs standard of care KRd); (2) No grade >3 peripheral neuropathy; (3) No deaths on study; (4) Total 30 dose reductions in 21 pts; majority were lenalidomide (N=15) and dexamethasone (N=12)https://twitter.com/DrOlaLandgren/status/1223056579077070849

[GeorgeBest]

News: GENMAB A/S <GMAB.CO>: GUGGENHEIM CUTS PRICE TARGET TO DKK 1760 FROM DKK 1804 - RTRS | News Wires | Thomson Reuters Eikon

[E_L]

Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis https://link.springer.com/article/10.1007%2Fs40263-020-00704-w full pdf
https://sci-hub.tw/https://link.springer.com/article/10.1007%2Fs40263-020-00704-w

[E_L]

https://sci-hub.tw/https://link.springer.com/article/10.1007%2Fs40263-020-00704-w

[E_L]

Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study https://www.nature.com/articles/s41375-020-0711-6

[Bulder]

Nice, PFS2 not yet reached.

[E_L]

CureVac and CEPI extend their Cooperation to Develop a Vaccine against Coronavirus nCoV-2019 https://www.curevac.com/news/curevac-and-cepi-extend-their-cooperation-to-develop-a-vaccine-against-coronavirus-ncov-2019

[E_L]

small chance, but IF they are successful we'll make a good return on the equity investment

[Sukkeralf]

Do we no what the 20 million euro equity investment mean in terms of ownership?

[E_L]

I have not seen that being disclosed
anywhere.

[E_L]

New Italian
Lymphoma trial https://www.clinicaltrials.gov/ct2/show/NCT04251065?cond=T+Cell+Lymphoma&sfpd_s=01%2F17%2F2020&sfpd_d=14&sel_rss=new14

[E_L]

GEN1046 now also starts to recruit in the US https://clinicaltrials.gov/ct2/history/NCT03917381?A=5&B=6&C=merged#StudyPageTop

[gdn55]

Nå, det er nok ikke mange der tror på en god fredags nyhed efter luk.

[Bella1]

Der er mexikansk Corona-øl på tilbud!, - pga. stagnerende salg

[Solsen]

NBI igen omkring -2,5%. Genmab klarer sig godt.

[Solsen]

Mon ikke det er nogle PMI tal der gør investorerne nervøse.